Today’s AI Top Pick: PBH

7/15/2026 · Model Aligned screen · a free sample of K3vl4r’s AI-curated picks.

AI-ranked from a screened shortlist, with entry strategy, targets, and risks.

Measured daily model accuracy · PBH75%164 resolved forecasts · 45d window · verify →

Today's pick · Model AlignedPBHBUY NOW8.2 / 107/15/2026

Prestige Consumer Healthcare (PBH) is the cleanest full-alignment setup in the pool today. Every timeframe forecasts positive returns: 1h fc_long +4.09%, 4h fc_mid/long +6.78%/+24.46%, 1d fc_mid/long +28.41%/+25.34%, and 1wk fc_mid/long +15.32%/+28.05%. Kronos bullish_prob is 1.0 and near_term_bullish is 1.0 — full confluence, no opposing TF. Unlike INTU or DOCS which sit high in their daily ranges, PBH sits at pos_in_21bar_range_pct 51% on the daily and only 5.5% on the weekly with a -30.75% weekly drawdown, meaning we are buying reset value rather than chasing extension. The fundamental profile is high-quality-value: PE 12.07, fwdPe 9.62, PEG 1.36, ROE 10.2, operMargin 28.4%, profitMargin 17.5%, debtEq 0.55, analyst recom 1.5 (Buy), and targetUpsidePct +39.9%. Fundamental_score is 6.25 — meaningfully positive without the caveats attached to LCID (bankruptcy rumors), INTU (legal strain headline + 'stock sinks' today), HCA (Barclays downgrade + sector selloff in UHS/THC), or CLS (opposing bullish_prob 0, negative 1d/1wk forecasts). The news flow is the tiebreaker. PBH just closed the LaCorium Health acquisition, priced $400M senior notes, and set a Q1 FY27 earnings date — three tangible near-term catalysts, plus an Ariel Investments 'top stock to buy' feature. There is no landmine headline. Compare that to INTU (highest forecast magnitudes at 1d fc_long +115.9%, but a 'legal strains diluting AI-tax narrative' piece and a same-day 'stock sinks' article) or LCID (whose +230% 1d forecast is completely undercut by Nasdaq halting trading on bankruptcy rumors). Today is the right entry because we have (a) multi-TF confluence pointing up, (b) a low-in-range weekly print giving asymmetric reward-to-risk, (c) a hard positive catalyst just executed (acquisition close + refinancing), and (d) earnings roughly two weeks out — the classic pre-print drift setup for a Buy-rated name near a swing low.

Entry zone

$47.50 – $48.20 (current $47.99, buy at market or into any dip toward the 4h VWAP)

Stop loss

$45.60 (below the 4h dd_from_21bar_high band of -4.76%, ~5% risk)

First target

$52.50 (aligns with 1d fc_mid +28% path first leg; ~9-10% gain)

Longer target

$60.00 – $61.50 (matches 1wk fc_long +28% and analyst targetUpsidePct +39.9%)

Risks

Sales growth is negative at -4.31% YoY — the acquisition thesis has to actually inflect the top line or the multiple compresses.
Earnings date lands within the swing window; a miss or soft guide could gap the stock through the $45.60 stop.
$400M new senior notes lifts leverage (debtEq already 0.55) at a time of higher rates — refinancing costs could pressure EPS.
Weekly recent_21bar_pct is -30.75%; if broader consumer/healthcare weakness continues (see HCA/UHS/THC selling today), PBH can grind lower before the forecast plays out.
Small-cap ($2.24B) with shortFloat 6.88% — thin liquidity can amplify downside on any negative surprise.

Honorable mentions

CELHFull 1.0/1.0 bullish alignment with the highest daily forecast among clean-news names (1d fc_mid +51.8%, fc_long +55.9%), Citi maintains Buy, recom 1.36, salesYoY +123%. Held back to #2 by 20% short float and elevated PE 71.95; weekly drawdown -43.7% signals broken trend structure still healing.

INTUHighest forecast magnitudes in the pool (1d fc_long +115.9%, 1wk fc_long +86.2%) and fundamental_score 8 with fwdPe 10.31 and PEG 0.67. Bumped to #3 because a 'legal strains' article and 'stock sinks as market gains' hit the same day, and pos_in_21bar_range on the daily is 79.5% (chase risk in the near term).

Full ranking (30)

#	Symbol	Verdict	Score	Read
1	PBH	BUY NOW	8.2	Full multi-TF confluence, mid-range entry, fresh acquisition catalyst, Buy rating, +39.9% target upside.
2	CELH	BUY NOW	7.8	1d fc_long +55.9% with 1.0/1.0 alignment and Citi Buy; short float 20% is the only real caveat.
3	INTU	BUY PULLBACK	7.5	Best forecast magnitudes and fundamentals but today's negative headlines and top-of-daily-range argue for a dip entry.
4	DOCS	BUY PULLBACK	7.2	Extreme 1d fc_mid +103% and clean alignment, but pos_in_21bar_range 71% daily and low targetUpside +11.2% cap conviction.
5	NOC	BUY NOW	6.8	Bullish_prob 1.0, near_term 0.8, mid-range daily, quality defense name with +27.9% target upside.
6	VIPS	BUY NOW	6.6	1.0/0.8 alignment, cheap at PE 6.57 / fwdPe 5.21, insider sale is minor noise; solid Chinese e-commerce rebound setup.
7	TYL	BUY NOW	6.4	All-TF positive forecasts (1d fc_mid +41.9%), Buy rating 1.48, +44.2% target; valuation stretched but AI product wins support.
8	CMCSA	BUY NOW	6.2	Deep value at PE 4.56 with 1.0/0.6 alignment and +39.2% target; data breach settlement now behind it.
9	GLPI	BUY NOW	5.9	1h/4h clean bullish, income anchor with 55% profit margin; upside limited (1d fc_long +2.74%).
10	SBAC	WAIT	5.7	Bullish alignment but pos_in_21bar 97% on 1h — chasing risk into earnings preview.
11	HCA	WAIT	5.4	Strong 1d/4h forecasts undercut by Barclays downgrade and negative hospital-sector news flow today.
12	TRB-USD	BUY PULLBACK	5.2	Crypto with 1.0/1.0 alignment and 1wk fc_long +57.8%, but 1d drawdown -19.4% shows volatility.
13	AA	BUY PULLBACK	5.0	Gallium plant catalyst is real, but 1d/1wk forecasts turn negative and RSI 32 shows momentum breakdown.
14	XLM-USD	WAIT	4.8	1h/4h up but 1d fc_short -4.98% and near_term_bullish 0 — no urgency.
15	WMT	WAIT	4.6	1wk forecasts collapse (-35%) despite near-term bullish; overvalued at fwdPe 34.65.
16	POPCAT-USD	BUY PULLBACK	4.5	Speculative meme with 1d fc_long +42.5% but near_term_bullish 0 — wait for confirmation.
17	PMT	WAIT	4.4	Bullish TFs but debtEq 10.87 and mixed analyst view; modest +21% target upside.
18	CDE	WAIT	4.2	Weekly forecast collapses to -68.7% and daily at range-lows; alignment score misleading.
19	SLV	WAIT	4.0	1h/4h bullish but 1wk fc_long -51% and heavy drawdown; wait for silver base to form.
20	WH	WAIT	3.9	Bullish_prob 0.8 but forecasts flat-to-negative across mid/long; no urgency.
21	RMBS	AVOID	3.6	Bullish_prob 0 and 1d/1wk forecasts turn deeply negative (-52% long); DDR5 hype already priced.
22	CLS	AVOID	3.4	Opposing bullish_prob 0 with 1d fc_mid -31.9% and 1wk fc_long -72.7% despite good fundamentals.
23	SLB	AVOID	3.2	Bullish_prob 0 with 1d/1wk fc_long -16% each; oil services momentum rolling over.
24	ERO	AVOID	3.0	Bullish_prob 0 with 1d fc_mid -12% and 1wk fc_long -28%; near range top on 1h/4h.
25	ZWS	AVOID	2.9	Bullish_prob 0, 1wk fc_long -30.4%; forecast rolls over hard.
26	SKR-USD	AVOID	2.5	1d fc_long -92.95% is a catastrophic divergence from short-TF bullishness.
27	GRWG	AVOID	2.4	Micro-cap, negative margins, bullish_prob 0.2, mixed forecasts — no edge.
28	MON-USD	AVOID	2.2	Bullish_prob 0 with 1d fc_long -34.4%; all mid/long horizons bearish.
29	PII	AVOID	2.0	Bullish_prob 0, negative margins, targetUpside +1%, all TF forecasts negative.
30	LCID	AVOID	1.5	Nasdaq trading halt and bankruptcy rumors — pure landmine despite +230% 1d forecast.

Get AI top picks & forecasts on any stock

K3vl4r screens the market daily and ranks the best setups with AI — forecasts, scored fundamentals & technicals, and multi-horizon price targets. Create a free account to explore them all.

Create your free account →

Already a member? Sign in · Join our Discord